{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Rodin D"],"funding":["NCI NIH HHS"],"pagination":["915-923"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7055962"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["20(7)"],"pubmed_abstract":["<h4>Background</h4>Radiotherapy is standard of care for cervical cancer, but major global gaps in access exist, particularly in low-income and middle-income countries. We modelled the health and economic benefits of a 20-year radiotherapy scale-up to estimate the long-term demand for treatment in the context of human papillomavirus (HPV) vaccination.<h4>Methods</h4>We applied the Global Task Force on Radiotherapy for Cancer Control investment framework to model the health and economic benefits of scaling up external-beam radiotherapy and brachytherapy for cervical cancer in upper-middle-income, lower-middle-income, and low-income countries between 2015 and 2035. We estimated the unique costs of external-beam radiotherapy and brachytherapy and included a specific valuation of women's caregi"],"journal":["The Lancet. Oncology"],"pubmed_title":["Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact."],"pmcid":["PMC7055962"],"funding_grant_id":["K08 CA230170","U54 CA190158"],"pubmed_authors":["Grover S","Zubizarreta E","Barton M","Hanna TP","Lievens Y","Jaffray DA","Atun R","Rodin D","Gospodarowicz M","Burger EA","Knaul FM","Milosevic M"],"additional_accession":[]},"is_claimable":false,"name":"Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact.","description":"<h4>Background</h4>Radiotherapy is standard of care for cervical cancer, but major global gaps in access exist, particularly in low-income and middle-income countries. We modelled the health and economic benefits of a 20-year radiotherapy scale-up to estimate the long-term demand for treatment in the context of human papillomavirus (HPV) vaccination.<h4>Methods</h4>We applied the Global Task Force on Radiotherapy for Cancer Control investment framework to model the health and economic benefits of scaling up external-beam radiotherapy and brachytherapy for cervical cancer in upper-middle-income, lower-middle-income, and low-income countries between 2015 and 2035. We estimated the unique costs of external-beam radiotherapy and brachytherapy and included a specific valuation of women's caregi","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Jul","modification":"2025-04-22T00:21:37.329Z","creation":"2020-10-29T15:41:40Z"},"accession":"S-EPMC7055962","cross_references":{"pubmed":["31151906"],"doi":["10.1016/S1470-2045(19)30308-0","10.1016/s1470-2045(19)30308-0"]}}